(3R)-3-amino-1-[3-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one phosphoperoxol hydrogen

• ChemBase编号: 177782
• 分子式: C16H16F6N5O5P
• 平均质量: 503.2929202
• 单一同位素质量: 503.07932459
• SMILES: c1(cc(c(cc1F)C[C@H](CC(=O)N1CCn2c(C1)nnc2C(F)(F)F)N)F)F.P(=O)(=O)OO
• Canonical SMILES: N[C@H](Cc1cc(F)c(cc1F)F)CC(=O)N1CCn2c(C1)nnc2C(F)(F)F.OOP(=O)=O
• InChI: InChI=1S/C16H15F6N5O.HO4P/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22;1-4-5(2)3/h4,6,9H,1-3,5,7,23H2;1H/t9-;/m1./s1
• InChIKey: MSUBASJQSBTRGJ-SBSPUUFOSA-N

名称和登记号

名称

• IUPAC标准名: (3R)-3-amino-1-[3-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one phosphoperoxol hydrogen
• IUPAC传统名: phosphoperoxol sitagliptin hydrogen
• 别名: 7-[(3R)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine-phosphate; Sitagliptin Phosphate

登记号

• CAS号: 654671-78-0
• PubChem SID: 164233692
• PubChem CID: 45040403

理论计算性质

• 质子受体: 4
• 质子供体: 1
• LogD (pH = 5.5): -1.583009
• LogD (pH = 7.4): -0.13560155
• Log P: 1.2572163
• 摩尔折射率: 87.4946 cm^3
• 极化性: 31.48081 Å^3
• 极化表面积: 77.04 Å^2
• 可自由旋转的化学键: 6
• 里宾斯基五规则: false

分子性质

理化性质

• 溶解度: Methanol; Water
• 外观: White Solid
• 熔点: 202-204°C

安全信息

• 保存条件: -20°C Freezer

详细说明

Toronto Research Chemicals - S491000

Sitagliptin is a trizolopyrazine dipeptidyl peptidase IV inhibitor. Sitagliptin has recently been approved for the therapy of type II diabetes.

参考文献

• Kim, D., et al.: J. Med. Chem. 48, 141 (2005)
• Ahren, B., et al.: Eur. J. Pharmacol. 521 164 (2005)
• Bergman, A., et al: Clin. Ther. 28, 55 (2006)